Abstract
Background/Aim: We investigated the expression of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) and HBV X protein (HBx) in human hepatocellular carcinoma (HCC) and evaluated the effect of high-concentration nucleos(t)ide analogs (NUCs) on liver tumor cell lines. Materials and Methods: This study consisted of three parts: part I used human blood and nontumor liver tissues; part II used human HCC and adjacent liver tissues; and part III used an HBV-expressing liver tumor cell line. Results: There were close correlations among blood and liver HBV DNA and liver cccDNA. HBV cccDNA and HBx were highly up-regulated in HCC compared to adjacent liver tissues despite NUC therapy. HBV cccDNA and HBx were highly up-regulated in the cccDNA-expressing HepG2.2.15 cell line. Their expression was down-regulated and apoptosis was induced by a very high concentration of NUCs in dose- and time-dependent manner. Conclusion: Very high concentrations of NUCs may have a novel potential to kill replicating HBV-expressing liver tumor cells.
Author supplied keywords
Cite
CITATION STYLE
Tak, E., Hwang, S., Lee, H. C., Ko, G. Y., Ahn, C. S., Yoon, Y. I., … Lee, S. G. (2016). Apoptosis of hepatitis B virus-expressing liver tumor cells induced by a high concentration of nucleos(t)ide analogue. Anticancer Research, 36(11), 6059–6069. https://doi.org/10.21873/anticanres.11195
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.